‘Grief Never Goes Away’: Community Rallies at Dunn With Cancer Run, Raises $1.6 Million for Brain Cancer Research

When the sun slipped behind the trees of Springbank Park on Saturday, the crowd that gathered there didn’t look like a typical marathon‑ready mob. Instead, you saw families clutching handmade signs, retirees strolling side‑by‑side with teenagers, and a few tear‑streaked faces that hinted at deeper stories beneath the upbeat music.

It was the seventh year of the Dunn With Cancer Run, a charity event named after longtime London resident Karen Dunn, whose own battle with glioblastoma – an aggressive form of brain cancer – ended in 2022. While the memory of her loss still sits heavy, organizers say grief never truly disappears; it simply reshapes into purpose, and this purpose was on full display Saturday.

Over 800 participants laced up their shoes, ranging from seasoned runners to first‑timers who confessed they’d never even jogged a block before. The run featured a 5‑km jog, a 10‑km race, and a family‑friendly “walk‑and‑talk” route, giving everyone a chance to move, remember, and donate.

Local businesses turned the park into a pop‑up bazaar of encouragement. The downtown coffee shop “Brewed Awakenings” handed out free espresso shots to the first fifty finishers, while “Maple Grove Market” donated a basket of locally sourced produce to the post‑race celebration. The generosity was palpable – every vendor, every volunteer, every passer‑by was there because the cause mattered.

At the finish line, organizer and former oncology nurse, Michael Patel, wiped a bead of sweat from his forehead and announced the total amount raised: $1.6 million. The figure stunned the crowd, especially considering the event’s modest origins just seven years ago when a handful of friends gathered for a simple 3‑km walk in memory of Karen.

“We set out to honor Karen’s spirit, but this has become so much more,” Patel said, his voice cracking slightly. “Every dollar here fuels research that could one day turn a glioblastoma diagnosis from a death sentence into a manageable condition.”

The money will be funneled directly to the Ontario Brain Institute’s Glioblastoma Research Program, a partnership that began in 2021. Researchers there are working on cutting‑edge immunotherapy trials, advanced imaging techniques, and personalized medicine approaches aimed at extending survival rates.

Among the runners was 12‑year‑old Maya Singh, whose older brother was diagnosed with glioblastoma last year. “I’m running because I want him to get better,” Maya told a local reporter, clutching a pink ribbon. “And because I want to help other kids who are scared like I was.”

Stories like Maya’s underscored the emotional weight of the day. For many, the run was less about speed and more about solidarity. As one senior participant, 68‑year‑old Tom Whittaker, noted, “I’m not a runner, but I’m here for my granddaughter. We’re all in this together, whether it’s a marathon or a battle against cancer.”

Beyond the finish line festivities – music, food trucks, and a silent auction of donated artwork – the event also offered a brief panel discussion featuring oncologists and survivor advocates. The conversation highlighted the current state of glioblastoma treatment, the promise of new drug trials, and the ongoing need for public support.

In a post‑event interview, city councilor Lisa Harlow praised the community’s effort: “London has always stepped up when someone is hurting. Tonight, we turned that pain into hope, and the $1.6 million will have a real, tangible impact on lives both now and in the future.”

Looking ahead, organizers announced plans to expand the run’s reach, aiming for a broader regional footprint and a target of $3 million by the 2029 edition. For now, though, the focus remains on celebrating what has already been achieved – a day where grief was not a barrier but a bridge connecting strangers into a unified force for change.

As the sun finally set, volunteers began packing up, but the ripple effect of their work will continue to echo in laboratories, hospital corridors, and, most importantly, in the hearts of those still fighting glioblastoma.